Company Search:
Advanced Search
Sponsored Links
Molecular Partners AG Company Snapshot
Molecular Partners AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Molecular Partners AG with three other miscellaneous service companies in Europe: Genoway of France (2018 sales of 10.80 million Euro [US$11.74 million] ), C4X Discovery Holdings PLC of the United Kingdom (£7.06 million [US$9.15 million] ), and Bioventix Plc which is also based in the United Kingdom (£8.75 million [US$11.34 million] ).

Sales Analysis. Molecular Partners AG reported sales of 10.36 million Swiss Francs (US$10.59 million) for the year ending December of 2018. This represents a sharp decrease of 48.3% versus 2017, when the company's sales were 20.02 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Molecular Partners AG
  Stock Performance Chart for Molecular Partners AG
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): 22.50
(Figures in Swiss Francs)
1 Week 5.1%   13 Weeks 4.7%  
4 Weeks 33.6%   52 Weeks 25.0%  
Molecular Partners AG Key Data:
  Ticker: MOLN Country: Switzerland
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 10,355,000
(Year Ending Jan 2019).
Employees: 118
  Currency: Swiss Francs Market Cap: 481,152,645
  Fiscal Yr Ends: December Shares Outstanding: 21,384,562
  Share Type: Namenaktie Closely Held Shares: 6,184,671
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.